Ziclumeran
Chemical
FDA Substance Registry (openFDA)
Learn more about this substance:
Ask ChatGPT
Google
PubChem
Wikipedia
EWG Skin Deep
INCIDecoder
ECHA
Chemical Identification
| CAS Number | 2305431-29-0 |
|---|
Known Aliases (7)
Common Name
cas9 mRNA
cas9 mRNA (mRNA000042)
messenger RNA (mRNA), 5' capped, encoding codon-optimised clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9), flanked by untranslated regions (UTR) with significant sequence homology to the Xenopus beta globin gene, and terminated with a polyadenylation (polyA) tail. A Kozak sequence precedes the open reading frame and the 5' cap is a synthetic anti-reverse cap analogue (ARCA); contains N1-methylpseudouridine instead of uridine (all-U>m1Ψ)
NTLA-2001 component mRNA000042
RNA (recombinant 5′-(m7Gm-(5′→5′)-ppp-G)-capped all uridine→N1-methylpseudouridine-substituted synthetic CRISPR-associated endodeoxyribonuclease CAS9 low codon A-optimized-specifying plus Xenopus laevis β-globin 5′-and 3′-untranslated flanking region-containing poly(A)-tailed messenger)
ziclumeran [INN]
ZICLUMERAN [USAN]
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | JJ5AS2HL3G |
Ziclumeran |
CAS: 2305431-29-0 INN: 12328 USAN: MN-129 SMS_ID: 300000023313 FDA UNII: JJ5AS2HL3G NCI_THESAURUS: C203205 |
Record Info
| ID | DMHw93kHo4SEjHJBUW8A7b |
|---|---|
| Created | April 10, 2026, 10:21 p.m. |
| Modified | April 10, 2026, 11:03 p.m. |
| Data Source | FDA Substance Registry (openFDA) |